Archive - June 4, 2015

There is much concern, as reported here on the risk/benefits of the use of mefloquine as a anti-malaria  medication for Peace Corps Volunteers.  It is important to raise awareness in the Peace Corps community about this issue. Here is the letter from Dr. Nevin Remington, a leading expert on this medication, to Peace Corps:  text to link to: http://www.remingtonnevin.com/rpcv20150305.pdf RPCVs were urged to read  Dr. Nevin’s letter and review some of the information posted about the drug and then write to Peace Corps Director Carrie Hessler-Radelet urging Peace Corps to accept Dr. Nevin’s recommendations.  See: https://peacecorpsworldwide.org/malaria-mefloquine-and-peace-corps-what-price-protection-part-one/ and https://peacecorpsworldwide.org/malaria-mefloquine-and-peace-corps-what-price-protection-part-two/ In reviewing the following correspondence, it is important to note that Peace Corps is currently being sued by a RPCV over the use of mefloquine. See: John Coyne’s article on the law suit by Sara Thompson: https://peacecorpsworldwide.org/rpcv-sara-thompson/ I would presume that there are legal issues involved that might influence Peace Corps’ public response. I followed my . . .